The CURE research team focuses on advancing personalised medicine by integrating regenerative medicine with precise, non-invasive diagnostics.
The goal is to develop therapeutic and diagnostic solutions tailored to each patient’s individual characteristics, based on reliable biological data and real clinical needs.
The project’s main focus is the development of regenerative therapies, which use cells and extracellular vesicles. At the same time, the group is conducting research into modern diagnostics for urological cancers, such as identification of biomarkers or metabolomic and volatomic analyses of urine. By focusing on development and research, the team’s methods are a single, cohesive process aimed at achieving set outcomes: therapeutic products, treatment protocols, diagnostic tools, technologies ready for implementation.
